Palomar/Laserscope
This article was originally published in The Gray Sheet
Executive Summary
Palomar grants Laserscope a non-exclusive 7.5% royalty-bearing sublicense to patents in the field of laser hair removal, including U.S. Patent No. 5,595,568 "Permanent Hair Removal Using Optical Pulses," and No. 5,735,844 entitled "Hair Removal Using Optical Pulses." Palomar previously granted a 7.5% sublicense for the same patents to Coherent (1"The Gray Sheet" May 3, 1999, p. 20)
You may also be interested in...
Palomar Medical Technologies
Laser hair removal device firm's planned recapitalization includes a one-for-seven reverse stock split. At an April 21 meeting shareholders also approved the sale of the firm's Star Medical Technologies semiconductor laser subsidiary to Coherent for $65 mil. in cash and an ongoing 7.5% royalty. Palomar owns 82% of Star and anticipates a net gain of about $49 mil. before taxes. Closing of the deal, announced in December, is expected "shortly" ("The Gray Sheet" Dec. 14, 1998, p. 8)
Fujifilm Demonstrates Health Specialism With European HealthTech Spinout
From X-ray film in 1936 to the world’s first digital X-ray system in 1983, Fujifilm has a long heritage in medical diagnostics.
Financing Quarterly Statistics, Q1 2024
During Q1, biopharmas brought in an aggregate $30.1bn in financing and device company fundraising totaled $2.8bn; while in vitro diagnostic firms and research tools players raised $724m.